Kai Health, an AI company focused on infertility care (CEO Hyejun Lee), announced on the 3rd that it signed a memorandum of understanding (MOU) with Mirae-wa-Heemang Obstetrics and Gynecology Clinic (Director Seung-jae Lee) to develop an “infertility solution.”

Through this agreement, the two organizations plan to jointly pursue:

Development of an AI-based infertility solution

Development of comprehensive infertility-related healthcare services

Seung-jae Lee, Medical Director of Mirae-wa-Heemang, said, “For more than 30 years, Mirae-wa-Heemang has provided treatments for infertile couples and has worked to support the entire journey through pregnancy and childbirth,” adding, “We hope this partnership will improve the success rate of infertility treatments and contribute to addressing Korea’s low birth rate.”

Hyejun Lee, CEO of Kai Health, said, “Infertility is a global issue affecting one in six couples, but success rates remain low, which leaves significant room for technological advancement,” adding, “Through this agreement, we want to help more couples have healthy babies.”

Kai Health is developing an AI solution that helps select high-quality embryos in order to improve infertility treatment success rates, which currently remain at around 30%. The company previously advanced to the final round of “Challenge! K-Startup 2022,” Korea’s largest startup competition held on November 24, and won the Excellence Award along with a prize of KRW 130 million.

Source: Medifonews · By Hyung-gyu Lee · Published Feb 6, 2023 · Originally published in Korean · English translation

Kai Health Signs MOU with Mirae-wa-Heemang Clinic to Develop an Infertility Solution